Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Propionic Acidemia is a rare, life-threatening metabolic disorder where the body cannot properly break down certain proteins and fats, leading to the toxic buildup of propionic acid and other harmful substances. Early diagnosis and lifelong management, typically involving a strictly controlled diet and medical supervision, are essential to prevent severe complications such as metabolic crises, developmental delays, and organ damage. What is Propionic Acidemia and how does it affect the body? Propionic Acidemia is an inherited organic acidemia caused by a deficiency in the enzyme propionyl-CoA carboxylase.
TL;DR: Propionic Acidemia is a rare, life-threatening metabolic disorder where the body cannot properly break down certain proteins and fats, leading to the toxic buildup of propionic acid and other harmful substances. Early diagnosis and lifelong management, typically involving a strictly controlled diet and medical supervision, are essential to prevent severe complications such as metabolic crises, developmental delays, and organ damage.
Propionic Acidemia is an inherited organic acidemia caused by a deficiency in the enzyme propionyl-CoA carboxylase. Because the body cannot process specific amino acids (methionine, threonine, isoleucine, and valine) and odd-chain fatty acids, toxic byproducts accumulate in the blood and tissues. This buildup acts like a poison, primarily affecting the central nervous system, heart, and liver. For the 17 individuals currently connected through the DiseaseMaps community, managing these systemic effects is a daily priority that requires careful coordination between metabolic specialists and families.
Propionic Acidemia is a genetic condition inherited in an autosomal recessive pattern, meaning an affected individual must inherit one mutated gene from each parent. The mutations occur in the PCCA or PCCB genes, which provide instructions for creating the two parts of the propionyl-CoA carboxylase enzyme. If parents are both carriers, there is a 25% chance with each pregnancy that the child will be born with the condition.
Propionic Acidemia is considered a rare disease, with an estimated global incidence ranging from 1 in 50,000 to 1 in 150,000 live births. Because it is included in newborn screening programs in many countries, many infants are identified shortly after birth before symptoms become severe. While the condition affects both males and females equally, the severity of symptoms can vary significantly between individuals based on their specific genetic mutation and how much residual enzyme activity they possess.
Symptoms often appear within the first few days of life, though some individuals may experience a milder, later-onset form. Recognizing the signs early is critical for preventing permanent neurological damage. Common clinical manifestations include:
While Propionic Acidemia shares similarities with other organic acidemias like Methylmalonic Acidemia, it is distinct in its specific enzyme deficiency and the profile of organic acids found in urine and blood tests. Unlike conditions where specific amino acids are restricted entirely, Propionic Acidemia requires a complex balance of protein restriction while ensuring the body receives enough nutrition for normal growth, often supplemented with specialized medical formulas.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.